SeaCrest Wealth Management’s Exelixis EXEL Stock Holding History

SeaCrest Wealth Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	-$4K	–	2160
2018 Q4	$4K	Hold	200	–	–	﹤0.01%	1754
2018 Q3	$4K	Hold	200	–	–	﹤0.01%	1909
2018 Q2	$4K	Sell	200 -200	-50%	-$4.14K	﹤0.01%	1863
2018 Q1	$9K	Hold	400	–	–	﹤0.01%	1614
2017 Q4	$12K	Buy	+400	New	+$10.6K	﹤0.01%	1529

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SeaCrest Wealth Management's EXEL Position: Q1 2019 in Review

SeaCrest Wealth Management sold out of Exelixis (EXEL) in Q1 2019, closing a stake of 200 shares — an estimated $4K sold.

SeaCrest Wealth Management first reported a position in EXEL in Q4 2017 and held it in 5 quarters. The position peaked at $12K in Q4 2017. 377 funds tracked by Wall St. Rank hold EXEL as of Q1 2019.

SeaCrest Wealth Management reported no remaining Exelixis position as of Q1 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 200 Exelixis shares in Q1 2019, an estimated $4K.
SeaCrest Wealth Management first reported a position in Exelixis in Q4 2017 and held it in 5 quarters.
SeaCrest Wealth Management's Exelixis position peaked at $12K in Q4 2017.
377 funds tracked by Wall St. Rank held Exelixis as of Q1 2019.

Based on SeaCrest Wealth Management's 13F filing for Q1 2019, filed 10 May 2019.